Mazindol - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for mazindol and what is the scope of patent protection?
Mazindol
is the generic ingredient in two branded drugs marketed by Wyeth Ayerst and Novartis, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.Summary for mazindol
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 48 |
Clinical Trials: | 4 |
Patent Applications: | 6,528 |
Formulation / Manufacturing: | see details |
DailyMed Link: | mazindol at DailyMed |
Recent Clinical Trials for mazindol
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
NLS Pharma Inc. | Phase 2 |
NLS Pharmaceutics | Phase 2 |
VA Connecticut Healthcare System | Phase 2 |
Medical Subject Heading (MeSH) Categories for mazindol
US Patents and Regulatory Information for mazindol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | SANOREX | mazindol | TABLET;ORAL | 017247-002 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Novartis | SANOREX | mazindol | TABLET;ORAL | 017247-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for mazindol
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Wyeth Ayerst | MAZANOR | mazindol | TABLET;ORAL | 017980-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | SANOREX | mazindol | TABLET;ORAL | 017247-002 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
Novartis | SANOREX | mazindol | TABLET;ORAL | 017247-001 | Approved Prior to Jan 1, 1982 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |